Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 1:21 AM
Ignite Modification Date:
2025-12-25 @ 11:29 PM
NCT ID:
NCT02960893
Group ID:
EG003
Title:
Placebo/Troriluzole - OLE Phase
Description:
Participants who received placebo during randomization phase, received Troriluzole 140 mg capsules orally QD for 48 weeks in the extension period and were allowed to participate in 288 weeks for expanded extension phase, for a total of 336 weeks of open-label treatment.
Deaths Number Affected:
1
Deaths Number At Risk:
None
Serious Number Affected:
9
Serious Number At Risk:
67
Other Number Affected:
50
Other Number At Risk:
67
Study:
NCT02960893
Results Section:
NCT02960893
Adverse Events Module:
NCT02960893